Literature DB >> 12950024

Adducin expression in cutaneous and oral lesions: alpha- and beta-adducin transcripts down-regulate with keratinocyte differentiation in stratified epithelia.

Sharn L Bowen1, Balvinder K Bloor, Irene M Leigh, Ahmad Waseem.   

Abstract

Adducin is a heterodimer of alpha- with beta- or gamma-subunits that regulates the assembly of the spectrin-based membrane skeleton in erythrocytes. Although adducin has been identified in various non-erythroid cells and tissues, it has been localized at intercellular junctions only in keratinocytes and epidermis. However, no data are available yet on the regulation of individual adducin genes in differentiating versus hyperproliferating keratinocytes. Due to the unavailability of mono-specific antibodies for individual adducins, this study has used RT-PCR and in situ hybridization to investigate the expression of alpha- and beta-adducins in cultured cells and in stratified epithelia including cutaneous and oral lesions. Using RT-PCR, the alpha-transcripts were consistently expressed in all cell lines tested, as well as in normal interfollicular epidermis, whereas the beta-transcripts were more variable and were strongly expressed in K562, A431, and primary keratinocytes. However, in normal skin, oral mucosa, and attached gingivae, the levels of alpha-transcripts closely paralleled those for the beta-subunit. In most normal tissues, adducin expression was observed primarily in the proliferating compartments including the basal layer and lower suprabasal layers. Expression of both genes was also up-regulated in skin diseases characterized by increased cell proliferation and keratinocyte activation, such as basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and psoriasis. It was observed that, in most cases, the expression of both alpha- and beta-adducin was accompanied by increased expression of the proliferation marker Ki-67 and keratins K6 and K16. Differentiating keratinocytes in normal epithelia as well as in tumours appear to suppress the expression of adducin transcripts. The data suggest that the expression of adducin genes may be linked to cell proliferation and starts to down-regulate at the onset of differentiation. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12950024     DOI: 10.1002/path.1389

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

1.  Beta-adducin and sodium-calcium exchanger 1 gene variants are associated with systemic lupus erythematosus and lupus nephritis.

Authors:  Giuseppe A Ramirez; Chiara Lanzani; Enrica P Bozzolo; Laura Zagato; Lorena Citterio; Nunzia Casamassima; Valentina Canti; Maria Grazia Sabbadini; Patrizia Rovere-Querini; Paolo Manunta; Angelo A Manfredi
Journal:  Rheumatol Int       Date:  2015-06-05       Impact factor: 2.631

2.  Characteristics of benign lymphoadenosis of oral mucosa.

Authors:  Shu-Xia Li; Shi-Feng Yu; Kai-Hua Sun
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

3.  A phosphorylation-related variant ADD1-rs4963 modifies the risk of colorectal cancer.

Authors:  Na Shen; Cheng Liu; Jiaoyuan Li; Xueqin Chen; Yang Yang; Ying Zhu; Yajie Gong; Jing Gong; Rong Zhong; Liming Cheng; Xiaoping Miao
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

Review 4.  Adducin in tumorigenesis and metastasis.

Authors:  Cong Luo; Jiayu Shen
Journal:  Oncotarget       Date:  2017-07-18

5.  Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion.

Authors:  P C Ma; M S Tretiakova; V Nallasura; R Jagadeeswaran; A N Husain; R Salgia
Journal:  Br J Cancer       Date:  2007-07-31       Impact factor: 7.640

6.  Increased expression of phosphorylated adducin in tumor cells.

Authors:  Cong Luo; Guirong Wang; Huang Ying; Jiayu Shen; Diana M Gilligan
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.